https://www.selleckchem.com/pr....oducts/gw806742x.htm
tep strategy combining the use of a panel of genes followed by whole-exome sequencing in negative cases. Existing microbiome-based disease prediction relies on the ability of machine learning methods to differentiate disease from healthy subjects based on the observed taxa abundance across samples. Despite numerous microbes have been implicated as potential biomarkers, challenges remain due to not only the statistical nature of microbiome data, but also the lack of understanding of microbial interactions which can be indicative of the